INPP5D and Alzheimer disease: To better understand the levels of active INPP5D in the human brain in the context of AD, we next examined human brain tissue (prefrontal cortex, PFC) from the ROS-MAP cohorts30–34 for protein expression of INPP5D by western blot and tandem mass tag-mass spectrometry (TMT-MS).